ClinicalTrials.gg
Enrolling by invitationNCT06814249Updated Feb 26, 2025

A Prospective Cohort Study on Ligation of Pancreatic Stump After Distal Pancreatectomy

An interventional study of ligation of pancreatic stump with a quantified force and Manual suturing or stapling closure. in Distal Pancreatectomy and Postoperative Pancreatic Fistula, sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-02-26.

Sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if igation of pancreatic stump with quantified force works in decrease postoperative pancreatic fistula following distal pancreatectomy. The main outcome measures are:

Postoperative pancreatic fistula; Postoperative hospital stay.

Researchers will compare ligation to other pancreatic stump closure techniques to see if it decrease postoperative pancreatic fistula and postoperative hospital stay following distal pancreatectomy.

Read the detailed description

Introduction The closure of pancreatic stump after distal pancreatectomy remains controversial. Currently, the main methods of pancreatic stump closure include manual suturing and stapler closure. However, both methods carry a high risk of pancreatic fistula, which may be associated with the difficulty of balancing the provision of sufficient pancreatic duct burst pressure and ensuring blood supply to the stump. Through in vitro experiments, we demonstrated that applying quantified ligation forces to pancreatic stumps can provide a pancreatic duct burst pressure of approximately 50-70 mmHg. This burst pressure is higher than the upper limit of normal pancreatic duct pressure and lower than the normal mean arterial pressure, theoretically balancing the pancreatic duct burst pressure and stump blood supply. Therefore, we designed this prospective cohort study to verify the above hypothesis.

Methods and analysis This is a prospective cohort study at single centre in China. The major eligibility criterion is the presence of lesions planned for distal pancreatectomy. The texture of the pancreas was determined by the surgeon and the first assistant during the operation as soft, medium, or hard. After severing the pancreas, the pancreas was ligated at 5 mm from the pancreatic stump with a quantified force. Postoperative regular follow-up will be performed. The primary outcomes included pancreatic fistula and postoperative hospital stay, and the secondary outcomes included intra-abdominal infection, incision infection, and postoperative treatment costs. The primary outcomes and secondary outcomes of patients in this cohort will be statistically compared with historical data using appropriate tests.

Ethics and dissemination The study has been approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology(2024-0833-02). The results of the study will be published in an international peer-reviewed journal.

02

Conditions studied

  • Distal Pancreatectomy
  • Postoperative Pancreatic Fistula

Keywords

  • Pancreatic surgery
  • Distal pancreatectomy
  • Pancreatic texture
  • Pancreatic stump ligation
  • Postoperative pancreatic fistula
03

In context

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is the lead sponsor of 172 studies on the registry; 136 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients fully understand this study, voluntarily participate, and sign the Informed Consent Form (ICF);
  • Age between 18 and 75 years old;
  • Planned for distal pancreatectomy (including body and tail of the pancreas);
  • The intended pancreatic transection line is located on the left side of the portal vein.

Exclusion criteria

Exclusion Criteria:

  • History of previous pancreatic surgery;
  • Additional surgical procedures required for the residual pancreas;
  • Proximal pancreatic duct obstruction, with planned anastomosis between the residual pancreas and the digestive tract;
  • Use of long-acting somatostatin analogues during the perioperative period;
  • Patients who are judged by the investigator to be unsuitable for participation in this study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Experimental group

    After severing the pancreas, the pancreas was ligated at 5 mm from the pancreatic stump with a quantified force.

    Other: ligation of pancreatic stump with a quantified force

  • Active comparator
    Control group

    Handle the pancreatic stump according to conventional methods (manual suturing or stapling closure).

    Other: Manual suturing or stapling closure.

Interventions

  • Otherligation of pancreatic stump with a quantified force

    After severing the pancreas, the pancreas was ligated at 5 mm from the pancreatic stump with a quantified force.

  • OtherManual suturing or stapling closure.

    Handle the pancreatic stump according to conventional methods (manual suturing or stapling closure).

06

What researchers measure

Primary outcomes

  1. Pancreatic fistula

    Postoperative pancreatic fistula adopts the definition proposed by the International Study Group of Pancreatic Surgery.

    Time frame: Up to half a year from enrollment

  2. Postoperative hospital stay

    Stay from operation to discharge.

    Time frame: Up to half a year from enrollment

Secondary outcomes

  1. Intra-abdominal infection

    Intra-abdominal infection is evaluated based on Common Terminology Criteria for Adverse Event (CTCAE) V.5.0.

    Time frame: Up to half a year from enrollment

  2. Incision infection

    Incision infection is evaluated based on Common Terminology Criteria for Adverse Event (CTCAE) V.5.0.

    Time frame: Up to half a year from enrollment

  3. Postoperative treatment costs

    Treatment costs of postoperative period.

    Time frame: Up to half a year from enrollment

07

Study locations

1 site
  • Uion Hospital, Tongji Medical College, HUST
    Wuhan, Hubei 430022, China
08

References and documents

Publications

  • Kaneda Y, Kimura Y, Saito A, Ae R, Kawahira H, Sata N. Pancreas Ligation Device for Distal Pancreatectomy: An Ex Vivo Follow-Up Porcine Study. Cureus. 2023 Sep 6;15(9):e44771. doi: 10.7759/cureus.44771. eCollection 2023 Sep. PubMed 37692176 ↗
  • Funamizu N, Sogabe K, Shine M, Honjo M, Sakamoto A, Nishi Y, Matsui T, Uraoka M, Nagaoka T, Iwata M, Ito C, Tamura K, Sakamoto K, Ogawa K, Takada Y. Association between the Preoperative C-Reactive Protein-to-Albumin Ratio and the Risk for Postoperative Pancreatic Fistula following Distal Pancreatectomy for Pancreatic Cancer. Nutrients. 2022 Dec 10;14(24):5277. doi: 10.3390/nu14245277. PubMed 36558435 ↗
  • Mungroop TH, van der Heijde N, Busch OR, de Hingh IH, Scheepers JJ, Dijkgraaf MG, Groot Koerkamp B, Besselink MG, van Eijck CH. Randomized clinical trial and meta-analysis of the impact of a fibrin sealant patch on pancreatic fistula after distal pancreatectomy: CPR trial. BJS Open. 2021 May 7;5(3):zrab001. doi: 10.1093/bjsopen/zrab001. PubMed 34137446 ↗
  • Matsuda T, Kawai C, Sakurai T. [NMR blood flow measurement and NMR angiography]. Nihon Rinsho. 1987 Jan;45(1):60-6. No abstract available. Japanese. PubMed 3820687 ↗
  • Abe K, Kitago M, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Yokose T, Endo Y, Kitagawa Y. High risk pathogens and risk factors for postoperative pancreatic fistula after pancreatectomy; a retrospective case-controlled study. Int J Surg. 2020 Oct;82:136-142. doi: 10.1016/j.ijsu.2020.08.035. Epub 2020 Aug 27. PubMed 32861892 ↗
  • Miao Y, Lu Z, Yeo CJ, Vollmer CM Jr, Fernandez-Del Castillo C, Ghaneh P, Halloran CM, Kleeff J, de Rooij T, Werner J, Falconi M, Friess H, Zeh HJ, Izbicki JR, He J, Laukkarinen J, Dejong CH, Lillemoe KD, Conlon K, Takaori K, Gianotti L, Besselink MG, Del Chiaro M, Montorsi M, Tanaka M, Bockhorn M, Adham M, Olah A, Salvia R, Shrikhande SV, Hackert T, Shimosegawa T, Zureikat AH, Ceyhan GO, Peng Y, Wang G, Huang X, Dervenis C, Bassi C, Neoptolemos JP, Buchler MW; International Study Group of Pancreatic Surgery (ISGPS). Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2020 Jul;168(1):72-84. doi: 10.1016/j.surg.2020.02.018. Epub 2020 Apr 2. PubMed 32249092 ↗
  • Rozich NS, Morris KT, Garwe T, Sarwar Z, Landmann A, Siems CB, Jones A, Butler CS, McGaha PK, Axtman BC, Edil BH, Lees JS. Blame it on the injury: Trauma is a risk factor for pancreatic fistula following distal pancreatectomy compared with elective resection. J Trauma Acute Care Surg. 2019 Dec;87(6):1289-1300. doi: 10.1097/TA.0000000000002495. PubMed 31765347 ↗
  • Ratnayake CBB, Wells C, Hammond J, French JJ, Windsor JA, Pandanaboyana S. Network meta-analysis comparing techniques and outcomes of stump closure after distal pancreatectomy. Br J Surg. 2019 Nov;106(12):1580-1589. doi: 10.1002/bjs.11291. Epub 2019 Oct 18. PubMed 31626341 ↗
  • Nagakawa Y, Hijikata Y, Osakabe H, Matsudo T, Soya R, Sahara Y, Takishita C, Shirota T, Kobayashi N, Nakajima T, Hosokawa Y, Ishizaki T, Katsumata K, Tsuchida A. Why Does Postoperative Pancreatic Fistula Occur After Hand-sewn Parenchymal Closure and Staple Closure in Distal Pancreatectomy? Surg Laparosc Endosc Percutan Tech. 2019 Apr;29(2):e15-e19. doi: 10.1097/SLE.0000000000000604. PubMed 30520812 ↗
  • de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal M, Busch O, Besselink M; Dutch Pancreatic Cancer Group. Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial. Ann Surg. 2019 Jan;269(1):2-9. doi: 10.1097/SLA.0000000000002979. PubMed 30080726 ↗
  • Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM, Behrman SW, Dickson EJ, Callery MP, Christein JD, Drebin JA, Hollis RH, House MG, Jamieson NB, Javed AA, Kent TS, Kluger MD, Kowalsky SJ, Maggino L, Malleo G, Valero V 3rd, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr. Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019 Jan;269(1):143-149. doi: 10.1097/SLA.0000000000002491. PubMed 28857813 ↗
  • Chang YR, Kang JS, Jang JY, Jung WH, Kang MJ, Lee KB, Kim SW. Prediction of Pancreatic Fistula After Distal Pancreatectomy Based on Cross-Sectional Images. World J Surg. 2017 Jun;41(6):1610-1617. doi: 10.1007/s00268-017-3872-3. PubMed 28091744 ↗
  • Jang JY, Shin YC, Han Y, Park JS, Han HS, Hwang HK, Yoon DS, Kim JK, Yoon YS, Hwang DW, Kang CM, Lee WJ, Heo JS, Kang MJ, Chang YR, Chang J, Jung W, Kim SW. Effect of Polyglycolic Acid Mesh for Prevention of Pancreatic Fistula Following Distal Pancreatectomy: A Randomized Clinical Trial. JAMA Surg. 2017 Feb 1;152(2):150-155. doi: 10.1001/jamasurg.2016.3644. PubMed 27784046 ↗
  • Noorani A, Rangelova E, Del Chiaro M, Lundell LR, Ansorge C. Delayed Gastric Emptying after Pancreatic Surgery: Analysis of Factors Determinant for the Short-term Outcome. Front Surg. 2016 Apr 25;3:25. doi: 10.3389/fsurg.2016.00025. eCollection 2016. PubMed 27200357 ↗
  • Mendoza AS 3rd, Han HS, Ahn S, Yoon YS, Cho JY, Choi Y. Predictive factors associated with postoperative pancreatic fistula after laparoscopic distal pancreatectomy: a 10-year single-institution experience. Surg Endosc. 2016 Feb;30(2):649-656. doi: 10.1007/s00464-015-4255-1. Epub 2015 Jun 20. PubMed 26091993 ↗
  • Paye F, Micelli Lupinacci R, Bachellier P, Boher JM, Delpero JR; French Surgical Association (AFC). Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment. Br J Surg. 2015 Feb;102(3):229-36. doi: 10.1002/bjs.9708. Epub 2014 Dec 22. PubMed 25533421 ↗
  • Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H. Isolated Roux-en-Y anastomosis of the pancreatic stump in a duct-to-mucosa fashion in patients with distal pancreatectomy with en-bloc celiac axis resection. J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):193-8. doi: 10.1002/jhbp.16. Epub 2013 Jul 22. PubMed 23878017 ↗
  • Rostas JW, Richards WO, Thompson LW. Improved rate of pancreatic fistula after distal pancreatectomy: parenchymal division with the use of saline-coupled radiofrequency ablation. HPB (Oxford). 2012 Aug;14(8):560-4. doi: 10.1111/j.1477-2574.2012.00499.x. Epub 2012 Jun 11. PubMed 22762405 ↗
  • Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G, Tomazic A, Bruns CJ, Busch OR, Farkas S, Belyaev O, Neoptolemos JP, Halloran C, Keck T, Niedergethmann M, Gellert K, Witzigmann H, Kollmar O, Langer P, Steger U, Neudecker J, Berrevoet F, Ganzera S, Heiss MM, Luntz SP, Bruckner T, Kieser M, Buchler MW. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011 Apr 30;377(9776):1514-22. doi: 10.1016/S0140-6736(11)60237-7. PubMed 21529927 ↗
  • Ferrone CR, Warshaw AL, Rattner DW, Berger D, Zheng H, Rawal B, Rodriguez R, Thayer SP, Fernandez-del Castillo C. Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates. J Gastrointest Surg. 2008 Oct;12(10):1691-7; discussion 1697-8. doi: 10.1007/s11605-008-0636-2. Epub 2008 Aug 13. PubMed 18704597 ↗
  • Kleeff J, Diener MK, Z'graggen K, Hinz U, Wagner M, Bachmann J, Zehetner J, Muller MW, Friess H, Buchler MW. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg. 2007 Apr;245(4):573-82. doi: 10.1097/01.sla.0000251438.43135.fb. PubMed 17414606 ↗
  • Okazaki K, Yamamoto Y, Ito K. Endoscopic measurement of papillary sphincter zone and pancreatic main ductal pressure in patients with chronic pancreatitis. Gastroenterology. 1986 Aug;91(2):409-18. doi: 10.1016/0016-5085(86)90576-7. PubMed 3721126 ↗
  • Okazaki K, Yamamoto Y, Kagiyama S, Tamura S, Sakamoto Y, Nakazawa Y, Morita M, Yamamoto Y. Pressure of papillary sphincter zone and pancreatic main duct in patients with chronic pancreatitis in the early stage. Scand J Gastroenterol. 1988 May;23(4):501-7. doi: 10.3109/00365528809093901. PubMed 3381070 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Sep 2025, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 20, 2024
First posted
Feb 7, 2025
StartActual
Nov 21, 2024
Primary completionEst.
Sep 30, 2025
CompletionEst.
Oct 31, 2025
Last update
Feb 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06814249
Responsible party
Sponsor
First posted
Feb 7, 2025
Start date
Nov 21, 2024
Primary completion
Sep 30, 2025 (estimated)
Completion
Oct 31, 2025 (estimated)
Last update
Feb 26, 2025

Study contacts

Shanmiao Gou, MD, Ph.D
principal investigator · Union Hospital, HUST, Wuhan, China

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion